申请人:KAWANISHI Yasuyuki
公开号:US20100292500A1
公开(公告)日:2010-11-18
The present invention provides a pharmaceutical composition for use as art NPY Y5 receptor antagonist comprising a compound or the formula (I):
wherein R
1
is lower alkyl, cycloalkyl or the like,
R
2
is hydrogen, lower alkyl or the like,
n is 1 or 2,
X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like,
Y is CONR
7
, CSNR
7
, NR
7
CO, NR
7
CS or the like,
Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like and R
7
is hydrogen or lower alkyl,
prodrug, pharmaceutically acceptable salt or solvate thereof.
本发明提供了一种药物组合物,用作NPY Y5受体拮抗剂,包括化合物或式(I):其中R1为低碳基、环烷基或类似物,R2为氢、低碳基或类似物,n为1或2,X为低碳基、低烯基、芳基、环烷基或类似物,Y为CONR7、CSNR7、NR7CO、NR7CS或类似物,Z为低碳基、可选取代的碳环基、可选取代的杂环基或类似物,R7为氢或低碳基,前药、药学上可接受的盐或溶剂。